Early Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis
|
|
- Beryl Nichols
- 6 years ago
- Views:
Transcription
1 Advances in Peritoneal Dialysis, Vol. 22, 2006 Hidetomo Nakamoto, 1,2 Hirokazu Imai, 2 Hideki Kawanishi, 2 Masahiko Nakamoto, 2 Jun Minakuchi, 2 Shinichi Kumon, 2 Syuichi Watanabe, 2 Yoshhiko Shiohira, 2 Takeo Ishii, 2 Toshihiko Kawahara, 2 Hiromichi Suzuki 1,2 Early Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis At the beginning of continuous ambulatory peritoneal dialysis (CAPD), different patients exhibit large differences in peritoneal permeability. To determine if early estimation of peritoneal permeability can predict the prognosis of CAPD, we used data from a personal dialysis capacity (PDC) study group in Japan to investigate patient and technique survival rates. Based on the data from a previously reported, prospective multicenter study encompassing eight dialysis centers in Japan (Am J Kidney Dis 2002; 40: ), we recalculated patient and technique survival data. We reviewed the records of 139 patients newly initiated on CAPD from January 1995 to December Peritoneal permeability was estimated by PDC test within the first year after initiation. We divided the patients into paired groups according to several peritoneal permeability variables as calculated by the PDC test (area, plasma loss, and peritoneal creatinine clearance), and we compared patient and technique survival rate between the groups. The mean age of the patients was 49.6 years ± 14.9 years (standard deviation). The mean pore area of peritoneum was 19,936 ± 8383 cm/1.73 m 2. Estimation of patient survival by the Kaplan Meier method showed 94.2%, 88.4%, 84.1%, and 79.7% at 1, 2, 3, and 5 years respectively. Estimated technique survival (including death as an endpoint) by the Kaplan Meier method showed 90.6%, 76.8%, 67.4%, and 54.3% at 1, 2, 3, and 5 years respectively. In the high peritoneal permeability group (high area and high plasma loss), the technique survival at 5 years was significantly lower than in the low peritoneal From: 1 Department of Nephrology, Saitama Medical School, and 2 Japan PDC Study group, Saitama, Japan. permeability group [area: 55.9% (high) vs. 72.7% (low), p = ; plasma loss: 43.3% (high) vs. 62.8% (low), p = ). We observed no significant difference in patient survival between the high and low peritoneal permeability patients. In the high peritoneal creatinine clearance group, patient and technique survival were both significantly lower than in the high peritoneal creatinine clearance group. Patients with high peritoneal permeability as calculated by the PDC test at the start of PD had a poor prognosis for technique and patient survival on CAPD. We conclude that early estimation of high peritoneal permeability can predict poor outcome for patients on CAPD. Key words Technique survival, CAPD, peritoneal permeability, personal dialysis capacity (PDC) test Introduction Until recently, evidence concerning the importance of urea clearance and creatinine clearance (CCr) in the prediction of outcome on peritoneal dialysis (PD) has been conflicting. Some previous reports indicated a link between survival and solute clearance (1 3). The CANUSA study, a multicenter prospective cohort study, showed that total weekly urea clearance and total weekly CCr (renal and peritoneal) both were independent and important predictors patient survival (4). The CANUSA study and other studies showed a correlation between small-solute clearance and outcome (4). Recently, the ADEMEX study clearly demonstrated that peritoneal small-solute clearance and clinical outcome are not correlated (5). Those data demonstrated the importance of residual renal
2 12 Nakamoto et al. function (RRF) as a predictor of mortality in patients on continuous ambulatory peritoneal dialysis (CAPD), perhaps causing peritoneal CCr to lose its significance. Hyperpermeability of the peritoneal membrane defined as fast or high transport as measured by peritoneal equilibration test (6) develops during long-term peritoneal dialysis (7). However, in some patients, a state of hyperpermeability may also present from the beginning of peritoneal dialysis (8). The meaning of early estimation of a state of high peritoneal permeability is unclear. At the beginning of CAPD, peritoneal permeability differs widely from patient to patient. To determine whether early estimation of peritoneal permeability can predict prognosis on CAPD, we used data from a personal dialysis capacity (PDC) study group in Japan to investigate patient and technique survival. Patients and methods Definition of technique survival One reason that comparing reported technique survival data is difficult relates to differences in definition. Some reports on technique survival include death and transplantation as endpoints; others do not (9). Blake (9) defines technique failure as any situation in which a patient on peritoneal dialysis (PD) switches to hemodialysis for more than 3 months; he excludes patients who are successfully transplanted or who recover RRF (10). He also excludes patients who die a decision that may be more controversial. PDC test The PDC test was provided by Gambro Shimizu Pharmaceutical Company (Gambro Shimizu, Tokyo, Japan) and was used on a version 3.1 system according to the manual by Haraldsson (11). Briefly, during the night before the study day, a 10-hour nighttime dwell was performed. If patients were on home automated peritoneal dialysis (APD), they were converted to a CAPD schedule during the PDC test. The overnight dwell preceding the test was weighed and sampled after mixing (the "zero" sample). The test itself started with a short (2- to 3-hour) PD dwell. That dwell was followed by two 4- to 6-hour intermediate dwells, another short exchange, and finally an overnight dwell (10 hours). Two different glucose concentrations were used in alternation. Well-mixed 10 ml dialysate samples from each dwell and two blood samples taken during the 24-hour period were analyzed. Albumin in dialysate was measured using an assay for micro-albumin or albumin. A 24-hour urine collection was also performed to measure RRF. The exact starting time of dialysate infusion and drainage, the time of blood sampling, the glucose concentration used, and the weight of bags with new and spent dialysate fluid were all carefully documented. Study protocol Based on data from a previously reported prospective multicenter study at eight dialysis centers in Japan (12,13), we recalculated survival rates. That study included 139 newly initiated CAPD/APD patients (72 men, 67 women). In those patients, a PDC study was performed within 6 months of CAPD start. We collected the data from the PDC tests between May 1995 and January Using the Kaplan Meier method, 5-year follow-up patient and technique survival were calculated for those patients. We then divided the patients into paired groups by pore area [>19936 cm/ 1.73 m 2 (high), < cm/1.73 m 2 (low)], plasma losses [>0.10 ml/min/1.73 m 2 (high), <0.10 ml/min/ 1.73 m 2 (low)], peritoneal CCr [>5.43 ml/min/ 1.73 m 2 (high), <5.43 ml/min/1.73 m 2 (low)], and total CCr (>7.30 ml/min/1.73 m 2 (high), <7.30 ml/ min/1.73 m 2 (low)]. We compared patient and technique survival between these four separate high and low groups. Statistical analysis All results are expressed as mean ± standard deviation. The analyses were performed using the StatView version 5.0 software (SAS Institute, Cary, NC, U.S.A.) on a Macintosh computer. The analyses of survival and of continuation rate on CAPD used the Kaplan Meier method, and the log-rank test was used for survival comparisons by PDC test factor and group. Results Characterization of the patients Table I shows the clinical and demographic characteristics of the patients. The mean age of the patients was 49.6 ± 14.9 years. Mean plasma protein level in the patients was 6.3 ± 0.8 g/dl; mean plasma albumin level was 3.5 ± 0.5 g/dl; and mean plasma glucose level was 98.7 ± 20.9 mg/dl.
3 High Peritoneal Permeability and Technique Survival in PD 13 PDC study data Table I also shows the results of the PDC study in the 139 patients. The mean pore area was 19,936 ± 8383 cm/1.73 m 2. The mean absorption rate was 1.48 ± 0.73 ml/min/1.73 m 2. The mean large-pore flow (plasma loss rate) was 0.10 ± 0.07 ml/min/1.73 m 2. The mean RRF was 1.88 ± 1.84 ml/min/1.73 m 2. The mean peritoneal CCr was 5.43 ± 1.09 ml/min/1.73 m 2. The mean total CCr was 7.30 ± 1.90 ml/min/1.73 m 2. The mean weekly Kt/V urea was ± The mean dietary calorie and protein intakes were ± kcal daily and 53.3 ± 10.8 g daily respectively. The mean 24-hour protein equivalent of nitrogen appearance/protein catabolic rate was 1.17 ± 0.36 g/kg. The mean urea generation rate was 0.11 ± 0.05 mmol/min. And the mean creatinine generation rate was 5.93 ± 2.24 mmol/24 hr. Patient and technique survival Patient survival was 94.2%, 88.4%, 84.1%, and 79.7% after 1, 2, 3, and 5 years respectively. Technique survival was 93.6%, 86.4%, 79.1%, and 68.2% after 1, 2, 3, and 5 years, respectively. Those data exclude patients who died. If patients who died are included, technique survival was 90.6%, 76.8%, 67.4%, and 54.3% after 1, 2, 3, and 5 years, respectively. TABLE I The clinical and demographic characteristics of the patients undergoing continuous ambulatory peritoneal dialysis Area (cm/1.73 m 2 ) 19,936±8383 Absorption (ml/min/1.73 m 2 ) 1.48±0.73 Plasma loss (ml/min/1.73 m 2 ) 0.10±0.07 Water permeability (ml/min/mmhg/1.73 m 2 ) 0.069±0.030 Peritoneal UF (ml/24 h) 1422±780 Urine volume (ml/24 h) 415.1±379.3 Total UF (ml/24 h) ±838.7 Peritoneal CCr (ml/min/1.73 m 2 ) 5.43±1.09 RRF (ml/min/1.73 m 2 ) 1.88±1.84 Total CCr (ml/min/1.73 m 2 ) 7.30±1.90 Kt/V urea 2.449±0.698 Protein loss from PD (g/24 h) 6.7±3.8 Dietary protein intake (g/24 h) 53.3±10.8 Calories from PD (kcal/24 h) 402.8±88.7 Dietary calorie intake (kcal/24 h) ±332.7 Urea generation rate (mmol/min) 0.11±0.05 Cr generation rate (mmol/24 hr) 5.93±2.24 Daily PNA/PCR (g/kg) 1.17±0.36 UF = ultrafiltration; CCr = creatinine clearance; RRF = residual renal function; Kt/V = dialysis adequacy; PD = peritoneal dialysis; Cr = creatinine clearance; PNA/PCR = protein equivalent of nitrogen appearance/protein catabolic rate. Effect of peritoneal permeability on patient and technique survival Figure 1 shows the effect of pore area on patient and technique survival rate. In the high-area group, technique survival at 5 years was significantly lower than in the low-area group [55.9% (high) vs. 72.7% (low), p = ]. On the other hand, we observed no significant difference in survival rate between the high and low pore area groups [72.7% (high) vs. 83.0% (low), p = ]. Effect of plasma loss on patient and technique survival Figure 2 shows the effect of plasma loss on patient and technique survival. In the high plasma loss group, technique survival at 5 years was significantly lower than in the low plasma loss group [43.3% (high) vs. 62.8% (low), p = ]. On the other hand, we observed no significant difference in survival rate between the high and low plasma loss patients [73.3% (high) vs. 84.6% (low), p = ]. Effect of peritoneal and total CCr on patient and technique survival Figure 3 shows the effect of peritoneal CCr on patient and technique survival. In the high peritoneal CCr group, patient and technique survival rates at 5 years were both significantly lower than in the low peritoneal CCr group [patient survival: 69.4% (high) vs. 88.2% (low), p = ; technique survival: 43.3% (high) vs. 62.8% (low), p = ]. On the other hand, total CCr had no effect on patient or technique survival [patient survival: 78.0% (high) vs. 80.7% (low), p = ; technique survival: 50.0% (high) vs. 56.8% (low), p = ; Figure 4]. Discussion In the present study, we used the PDC test to calculate peritoneal permeability in 139 newly initiated CAPD/APD patients. Our data clearly demonstrate that high peritoneal permeability as assessed by PDC is associated with poor prognosis for patient and technique survival in patients on CAPD. We conclude that early estimation of high peritoneal permeability can predict a poor prognosis for technique survival in patients on CAPD. In 1992, Rippe (14) introduced the three-pore model of the peritoneal membrane for the transport
4 14 Nakamoto et al. FIGURE 1 Effect of peritoneal area on patient and technique survival in 139 newly started continuous ambulatory peritoneal dialysis (CAPD) patients. In the high-area group, the technique survival at 5 years was significantly lower than in the low area group (55.9% vs. 72.7%, p = ). No significant difference in patient survival was observed between high- and low-area patients [72.7% (high) vs. 83.0% (low), p = ]. of solutes. Following from that concept, Haraldsson (11) developed a computer program for peritoneal function analysis, calling it the PDC test. The PDC computer program calculates the three physiologic parameters of the peritoneum: Pore area (total pore area divided by diffusion distance available for exchange) Absorption (final rate of fluid reabsorption from the abdominal cavity when the osmotic gradient has dissipated) Plasma loss (rate of protein-rich fluid passing through the large pores from blood to dialysate) FIGURE 2 Effect of plasma loss on patient and technique survival in 139 newly started continuous ambulatory peritoneal dialysis (CAPD) patients. In the high plasma loss group, technique survival at 5 years was significantly lower than in the low plasma loss group [43.3% (high) vs. 62.8% (low), p = ]. No significant difference in patient survival was observed between the high and low plasma loss patients [73.3% (high) vs. 84.6% (low), p = ]. A small number of reports regarding the clinical application of PDC testing have appeared thus far (12,13,15). The useful features of the PDC test are the convenience of entering data during routine dialysis (two blood samples in 24 hours), the abundant results regarding peritoneal function and diet, ease in recommending dialysis treatment for each patient, and accurate comparison of digitized data in both the clinical course of individual patients and in large studies (11,16). Recently, some clinical applications of the PDC test have been reported. Imai et al. (15) found that the PDC test is useful for evaluating change in peritoneal
5 High Peritoneal Permeability and Technique Survival in PD 15 FIGURE 3 Effect of peritoneal creatinine clearance on patient and technique survival. In the high peritoneal creatinine clearance group, patient and technique survival rates at 5 years were both significantly lower than in the low peritoneal creatinine clearance group [patient survival: 69.4% (high) vs. 88.2% (low), p = ; technique survival: 43.3% (high) vs. 62.8% (low), p = ]. function on CAPD. Schaefer et al. (17) reported that the PDC test allowed peritoneal solute and water transport to be modeled with remarkable precision in children of all age groups. More recently, Heaf and colleagues (18) reported that a high peritoneal largepore fluid flux (JVc) as calculated by PDC test resulted in increased peritoneal protein losses. The JVc is related to hypoalbuminemia and mortality after PD initiation. A high JVc seems to be a marker of preexisting vascular pathology, which causes hypoalbuminemia after PD initiation. However, no studies have clearly evaluated the association between peritoneal permeability and clinical outcome using this kind of analysis tool. FIGURE 4 Effect of total creatinine clearance on patient and technique survival. Total creatinine clearance had no effect on patient and technique survival [patient survival: 78.0% (high) vs. 80.7% (low), p = ; technique survival: 50.0% (high) vs. 56.8% (low), p = ]. In the present study, to determine whether early estimation of peritoneal permeability can predict the prognosis of patient and technique survival in patients on CAPD, we reanalyzed data from a multicenter study that used the PDC test. Our study demonstrated that early diagnosis of high peritoneal CCr is associated with higher mortality and lower technique survival in patients on CAPD. This high peritoneal CCr was induced by high peritoneal permeability. On the other hand, high protein losses in dialysate and a high area parameter are associated with lower technique survival, but have no association with patient survival. This discrepancy may be attributable to the small number of patients in the study. However the data demonstrated another possibility: that high small-solute
6 16 Nakamoto et al. losses from the peritoneum may be an independent risk factor for patient survival. High peritoneal permeability had a clearly demonstrated association with poor clinical outcome in patients on CAPD. Previously, CAPD patients with high peritoneal permeability have been shown to have a paradoxically higher morbidity and mortality (10,19). Increased peritoneal transport may be associated with increased removal of uremic solutes, thereby improving patient and technique survival. In the CANUSA study (10), three possible explanations were advanced. First, high peritoneal permeability patients lose ultrafiltration capacity because of rapid equilibration of glucose across the peritoneal membrane, with consequent overhydration and hypertension. Second, high peritoneal permeability patients typically also have large-pore transport, leading to excessive loss of protein with consequent protein malnutrition. Third, high peritoneal permeability patients were noted to already suffer from hypoalbuminemia at the time of their first peritoneal equilibration test, 1 month after the start of dialysis, and hypoalbuminemia is a powerful predictor of mortality. Increased peritoneal permeability induces additional loss of protein from the peritoneum, inducing malnutrition. Rapid absorption of glucose from the dialysate may reduce appetite and contribute to malnutrition. In such patients, repeated use of hypertonic dialysis exchanges may increase the carbohydrate load, possibly suppressing appetite and reducing protein intake. These multiple factors may induce malnutrition and poor clinical outcome. Although protein loss is greater in the high transport group after initiation of PD, high loss of protein cannot explain why some patients have lower baseline serum albumin levels. Our data demonstrated that total CCr has no effect on patient and technique survival in patients on CAPD. Those data are supported by previous reports (5,20). On the other hand, high peritoneal CCr is a strong predictor of higher mortality and lower technique survival. Considering peritoneal CCr plus CCr from RRF (total CCr), we can speculate that low RRF may be an important predictor of high mortality. In the ADEMEX study, it was reported that peritoneal small-solute clearance is not as critical as RRF for the survival of CAPD patients. In patients starting PD, a low initial RRF and inflammation are both associated with high overall mortality (21). High peritoneal permeability was associated with higher mortality, but only during the initial year on PD (22). Conclusions Our data clearly demonstrate that high peritoneal permeability measured early in patients initiated on CAPD was associated with poor prognosis for patient and technique survival. We conclude that an early estimation of high peritoneal permeability can predict poor prognosis for technique survival in patients on CAPD. References 1 Teehan BP, Schleifer CR, Brown JM, Sigler MH, Raimondo J. Urea kinetic analysis and clinical outcome in CAPD. A five year longitudinal study. Adv Perit Dial 1990; 6: Selgas R, Bajo MA, Fernandez Reyes MJ, et al. An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kinetics. Nephrol Dial Transplant 1993; 8: Maiorca R, Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: Churchill DN, Taylor DW, Keshaviah PR, and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: Paniagua R, Amato D, Vonesh E, et al., for the Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7: Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: Selgas R, Bajo MA, Cirugeda A, et al. Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function. Perit Dial Int 2005; 25: Blake PG. Trends in patient and technique survival in peritoneal dialysis and strategies: how are we doing and how we can do better? Adv Ren Replace Ther 2000; 7:
7 High Peritoneal Permeability and Technique Survival in PD Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada U.S.A. (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9: Haraldsson B. Assessing the peritoneal dialysis capacities of individual patients. Kidney Int 1995; 47: Nakamoto H, Imai H, Kawanishi H, et al. Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD. Am J Kidney Dis 2002; 40: Nakamoto H, Suzuki H, for the Japan PDC Study Group. Hypoproteinemia in DM patients is attributable to high permeability of peritoneal membrane undergoing CAPD. Perit Dial Int 2003; 23(Suppl 2):S Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1993; 13(Suppl 2):S Imai H, Satoh K, Ohtani H, et al. Clinical application of personal dialysis capacity (PDC) test: serial analysis of peritoneal function in CAPD patients. Kidney Int 1998; 54: Vonesh EF, Burkart J, McMurray SD, Williams PF. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study. Perit Dial Int 1996; 16: Schaffer F, Haraldsson B, Haas S, Simkova E, Feber J, Mehls O. Estimation of peritoneal mass transport by three-pore model in children. Kidney Int 1998; 54: Heaf JG, Sarac S, Afzal S. A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: Heaf JG. CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate. Ren Fail 1995; 17: Lo WK, Ho YW, Li CS, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64: Wang AY, Lam CW, Wang M, et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis 2005; 45: Szeto CC, Law MC, Wong TY, Leung CB, Li PK. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study. Am J Kidney Dis 2001; 37: Corresponding author: Hidetomo Nakamoto, MD, Department of Nephrology, Saitama Medical School, 38 Morohongo, Moroyamamachi, Iruma-gun, Saitama Japan. nakamo_h@saitama-med.ac.jp
3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane
3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy
More informationPART ONE. Peritoneal Kinetics and Anatomy
PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.
More informationPeritoneal Dialysis Adequacy: Not Just Small- Solute Clearance
Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES
Date written: January 2004 Final submission: May 2004 Peritoneal transport and ultrafiltration GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationChapter 2 Peritoneal Equilibration Testing and Application
Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationContinuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
Advances in Peritoneal Dialysis, Vol. 33, 2017 Kunal Malhotra, Ramesh Khanna Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
More informationMaintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription
Advances in Peritoneal Dialysis, Vol. 34, 2018 Susie Q. Lew Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription Urea kinetics (weekly Kt/V) greater than 1.7 generally define
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationAna Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto
Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate
More information2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home
Fluid Management 2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home Objectives Define euvolemia Determine factors which contribute to fluid imbalance Discuss strategies
More informationThe greatest benefit of peritoneal dialysis (PD) is the
Peritoneal Dialysis International, Vol. 26, pp. 150 154 Printed in Canada. All rights reserved. 0896-8608/06 $3.00 +.00 Copyright 2006 International Society for Peritoneal Dialysis COMBINATION THERAPY
More informationPredictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran
Dialysis Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Monir Sadat Hakemi, 1 Mehdi Golbabaei, 2 Amirahmad Nassiri, 3 Mandana
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE This quick reference guide will help serve as a reference tool for clinicians setting a patient s Peritoneal Dialysis (PD) prescription.
More informationThe peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings
Peritoneal Dialysis International, Vol. 27, pp. 441 445 Printed in Canada. All rights reserved. 0896-8608/07 $3.00 +.00 Copyright 2007 International Society for Peritoneal Dialysis THE SHORT PET IN PEDIATRICS
More informationOriginal Article. Key words: Icodextrin, peritoneal dialysis, metabolic effects, ultrafiltration
Original Article 133 Clinical Experience of One-Year Icodextrin Treatment in Peritoneal Dialysis Patients Chun-Shuo Hsu *, Chien-Yu Su **, Chih-Hung Chang ***, Kao-Tai Hsu **, King-Kwan Lam **, Shang-Chih
More information02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN
Assessment of the Peritoneal Membrane: Practice Workshop Marina Villano, MSN, RN, CNN marina.villano@fmc-na.com Objectives Briefly review normal peritoneal physiology including the three pore model. Compare
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES
Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR
More informationAdequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial
http://www.kidney-international.org & 2006 International Society of Nephrology original article Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled
More informationWhat is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test
1 2 3 What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 4 Background information about the PET 1983 Dr. Twardowski and colleagues began measuring
More informationEvaluation and management of nutrition in children
Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence
More informationAdvances in Peritoneal Dialysis, Vol. 29, 2013
Advances in Peritoneal Dialysis, Vol. 29, 2013 Takeyuki Hiramatsu, 1 Takahiro Hayasaki, 1 Akinori Hobo, 1 Shinji Furuta, 1 Koki Kabu, 2 Yukio Tonozuka, 2 Yoshiyasu Iida 1 Icodextrin Eliminates Phosphate
More informationEffect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study
Kidney International, Vol. 64 (2003), pp. 649 656 DIALYSIS TRANSPLANTATION Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study WAI-KEI LO, YIU-WING HO, CHUN-SANG
More informationPredicting Clinical Outcomes in Peritoneal Dialysis Patients Using Small Solute Modeling
46 Annals of Clinical & Laboratory Science, vol. 35, no. 1, 2005 Predicting Clinical Outcomes in Peritoneal Dialysis Patients Using Small Solute Modeling Justin Westhuyzen, 1 Karen Mills, 2 and Helen Healy
More informationSurvival of Patients Over 75 Years of Age on Peritoneal Dialysis Therapy
Advances in Peritoneal Dialysis, Vol. 26, 2010 Hiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, Tomohiro Kikuta, Takahiko Sato, Masahiro Tsuda Survival of Patients Over 75 Years of Age on Peritoneal Dialysis
More informationPeritoneal Solute Transport Rate as an Independent Risk Factor for Total and Cardiovascular Mortality in a Population of Peritoneal Dialysis Patients
Advances in Peritoneal Dialysis, Vol. 30, 2014 Katarzyna Janda, 1 Marcin Krzanowski, 1 Paulina Dumnicka, 2 Beata Kuśnierz Cabala, 3 Przemysław Miarka, 1 Władysław Sułowicz 1 Peritoneal Solute Transport
More informationThe Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival
ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,
More informationProceedings of the ISPD 2006 The 11th Congress of the ISPD /07 $ MAXIMIZING THE SUCCESS OF PERITONEAL DIALYSIS IN HIGH TRANSPORTERS
Proceedings of the ISPD 2006 The 11th Congress of the ISPD 0896-8608/07 $3.00 +.00 August 25 29, 2006, Hong Kong Copyright 2007 International Society for Peritoneal Dialysis Peritoneal Dialysis International,
More informationPeritoneal Dialysis Prescriptions: A Primer for Nurses
Peritoneal Dialysis Prescriptions: A Primer for Nurses A Primer ABCs of PD R x Betty Kelman RN-EC MEd CNeph (C) Toronto General Hospital University Health Network Toronto, Ontario, Canada A moment to remember
More informationEffect of Initial PET Status on Clinical Course in Peritoneal Dialysis Patients
BANTAO Journal 2015; 13(1): 14-19; doi:10.1515/bj-2015-0004 BJ BANTAO Journal Original article Effect of Initial PET Status on Clinical Course in Peritoneal Dialysis Patients Tamer Sakaci¹, Yener Koc²,
More informationDetermination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1
Determination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1 Michael V. Rocco,2 Jean R. Jordan, and John M. Burkart MV. Rocco, J.M. Burkart,
More informationVolume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients
Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant
More informationTidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis
Kidney International, Vol. 57 (2000), 2603 2607 Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis PETER H. JUERGENSEN, A. LOLA MURPHY, KATHY A. PHERSON,
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE TABLE OF CONTENTS Introduction.... 3 SECTION 1: FUNDAMENTALS OF THE PRESCRIPTION.... 4 Getting Started: Patient Pathway to First Prescription.... 5 Volume
More informationSt George & Sutherland Hospitals PERITONEAL DIALYSIS UNIT RENAL DEPARTMENT Workplace Instruction (Renal_SGH_WPI_097)
PERITONEAL DIALYSIS (PD) PERITONEAL EQUILIBRATION TEST (PET) Cross references NSW Health PD2007_036 - Infection Control Policy SGH-TSH CLIN027 - Aseptic Technique - Competency and Education Requirements
More informationLLL Session - Nutritional support in renal disease
ESPEN Congress Leipzig 2013 LLL Session - Nutritional support in renal disease Peritoneal dialysis D. Teta (CH) Nutrition Support in Patients undergoing Peritoneal Dialysis (PD) Congress ESPEN, Leipzig
More informationNew Modality of Dialysis Therapy: Peritoneal Dialysis First and Transition to Home Hemodialysis
Advances in Peritoneal Dialysis, Vol. 28, 2012 Hiromichi Suzuki, Hitosi Hoshi, Tsutomu Inoue, Tomohiro Kikuta, Masahiro Tsuda, Tsuneo Takenaka New Modality of Dialysis Therapy: Peritoneal Dialysis First
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationMethods. Original Article. Abstract
Original Article Influence of Peritoneal Transport Characteristics on Nutritional Status and Clinical Outcome in Chinese Diabetic Nephropathy Patients on Peritoneal Dialysis Ji Chao Guan 1,2, Wei Bian
More informationPeritoneal transport testing
THOROUGH CRITICAL APPRAISAL www.sin-italy.org/jnonline www.jnephrol.com Peritoneal transport testing Vincenzo La Milia Nephrology and Dialysis Department, A. Manzoni Hospital, Lecco - Italy Ab s t r a
More informationPD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014.
PD prescribing for all Pr Max Dratwa Honorary consultant, Nephrology-Dialysis CHU Brugmann Université Libre de Bruxelles BSN 22 March 2014 QUESTION: Which approach? One size fits all or haute couture?
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 22, 2006 Costas Fourtounas, Eirini Savidaki, Marilena Roumelioti, Periklis Dousdampanis, Andreas Hardalias, Pantelitsa Kalliakmani,
More informationDrug Use in Dialysis
(Last Updated: 08/22/2018) Created by: Socco, Samantha Drug Use in Dialysis Drambarean, B. (2017). Drug Use in Dialysis. Lecture presented at PHAR 503 Lecture in UIC College of Pharmacy, Chicago. DIALYSIS
More informationVincenzo La Milia 1, Giuseppe Pontoriero 1, Giovambattista Virga 2 and Francesco Locatelli 1
Nephrol Dial Transplant (2015) 30: 1741 1746 doi: 10.1093/ndt/gfv275 Advance Access publication 16 July 2015 Ionic conductivity of peritoneal dialysate: a new, easy and fast method of assessing peritoneal
More informationDialysis therapy remains the mainstay in the treatment
Proceedings of the ISPD 2006 The 11th Congress of the ISPD 0896-8608/07 $3.00 +.00 August 25 29, 2006, Hong Kong Copyright 2007 International Society for Peritoneal Dialysis Peritoneal Dialysis International,
More informationPeritoneal dialysis adequacy: A model to assess feasibility with various modalities
Kidney International, Vol. 55 (1999), pp. 2493 2501 Peritoneal dialysis adequacy: A model to assess feasibility with various modalities JOSE A. DIAZ-BUXO, FRANK A. GOTCH, TOM I. FOLDEN, SHELDEN ROSENBLUM,
More informationAdvances in Peritoneal Dialysis, Vol. 27, 2011
Advances in Peritoneal Dialysis, Vol. 27, 2011 Eriko Kojima, Tsutomu Inoue, Keita Sueyoshi, Takahiko Sato, Masahiro Tsuda, Tomohiro Kikuta, Yusuke Watanabe, Hiroshi Takane, Tsuneo Takenaka, Hiromichi Suzuki
More informationDaily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients
2322 X. Lin et al. gy data. Journal of the American Statistical Association 1993; 88: 400 409 32. Bodnar E, Blackstone EH. An actual problem: another issue of apples and oranges. J Thorac Cardiovasc Surg
More informationHyperphosphatemia is a strong predictor of overall
Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics Sunil V. Badve,* Deborah L. Zimmerman,* Greg A. Knoll, * Kevin D. Burns,*
More informationPERITONEAL EQUILIBRATION TEST. AR. Merrikhi. MD. Isfahan University of Medical Sciences
PERITONEAL EQUILIBRATION TEST AR. Merrikhi. MD. Isfahan University of Medical Sciences INTRODUCTION The peritoneal equilibration test (PET) is a semiquantitative assessment of peritoneal membrane transport
More informationWhat Does Peritoneal Thickness in Peritoneal Dialysis Patients Tell Us?
Advances in Peritoneal Dialysis, Vol. 23, 2007 Soner Duman, 1 Suha Sureyya Ozbek, 2 Ebru Sevinc Gunay, 1 Devrim Bozkurt, 1 Gulay Asci, 1 Savas Sipahi, 1 Fatih Kirçelli, 1 Muhittin Ertilav, 1 Mehmet Özkahya,
More informationDe Novo Hypokalemia in Incident Peritoneal Dialysis
Original investigation 73 1) De Novo Hypokalemia in Incident Peritoneal Dialysis Patients: A 1-Year Observational Study Ji Yong Jung, M.D., Jae Hyun Chang, M.D., Hyun Hee Lee, M.D., Wookyung Chung, M.D.
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metaolism and Nutrition Advances in Peritoneal Dialysis, Vol. 19, 2003 Antonios H. Tzamaloukas, 1 Glen H. Murata, 2 Dorothy J. Vanderjagt, 3 Karen S. Servilla, 1 Roert H. Glew 3 Normalization
More informationSequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport
Nephrol Dial Transplant (2013) 28: 447 454 doi: 10.1093/ndt/gfs592 Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport Magda Galach 1, Stefan Antosiewicz
More informationBrief communication (Original)
Asian Biomedicine Vol. 8 No. 1 February 2014; 67-73 DOI: 10.5372/1905-7415.0801.263 Brief communication (Original) Long-term clinical effects of treatment by daytime ambulatory peritoneal dialysis with
More informationAcid-base profile in patients on PD
Kidney International, Vol. 6, Supplement 88 (23), pp. S26 S36 Acid-base profile in patients on PD SALIM MUJAIS Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois Acid-base profile in patients
More informationFree water transport: Clinical implications. Sodium sieving during short very hypertonic dialysis exchanges
Free water transport: Clinical implications Raymond T Krediet, MD,PhD University of Amsterdam Sodium sieving during short very hypertonic dialysis exchanges Nolph KD et al. Ann Int Med 1969;70:931-947
More informationUnrestricted pore area (A 0 / x) is a better indicator of peritoneal membrane function than PET
Kidney International, Vol. 58 (2000), pp. 1773 1779 Unrestricted pore area (A 0 / x) is a better indicator of peritoneal membrane function than PET EVA JOHNSSON, ANN-CATHRINE JOHANSSON, BRITT-INGER ANDREASSON,
More informationad e quate adjective \ˈa-di-kwət\
PD Prescriptions and Adequacy Monitoring: The Basics Fundamentals of Dialysis in Children Seattle, Washington February 27th, 2016 Colin White Steve Alexander Brad Warady Alicia Neu Franz Schaefer Bruce
More informationA longitudinal, five year survey of urea kinetic parameters in
Kidney International, Vol. 42 (1992), pp. 426 432 A longitudinal, five year survey of urea kinetic parameters in CAPD patients NORBERT H. LAMEIRE, RAYMOND VANHOLDER, DENISE veyt, MARIE-CHRISTINE LAMBERT,
More informationStrategies to Preserve the Peritoneal Membrane. Reusz GS Ist Dept of Pediatrics Semmelweis University, Budapest
Strategies to Preserve the Peritoneal Membrane Reusz GS Ist Dept of Pediatrics Semmelweis University, Budapest Outline 1. Structure of the peritoneal membrane 2. Mechanisms of peritoneal injury 3. Signs
More informationEfficacy and Safety of Ezetimibe and Low-Dose Simvastatin as Primary Treatment for Dyslipidemia in Peritoneal Dialysis Patients
Advances in Peritoneal Dialysis, Vol. 26, 2010 Hiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, Tomohiro Kikuta, Takahiko Sato, Masahiro Tsuda Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin
More informationPhysiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT
Physiology of Blood Purification: Dialysis & Apheresis Jordan M. Symons, MD University of Washington School of Medicine Seattle Children s Hospital Outline Physical principles of mass transfer Hemodialysis
More informationAchieving adequate fluid and sodium removal (NaR)
Peritoneal Dialysis International, Vol. 33, pp. 646 654 doi: 10.3747/pdi.2012.00261 0896-8608/13 $3.00 +.00 Copyright 2013 International Society for Peritoneal Dialysis AUTOMATED PERITONEAL DIALYSIS PRESCRIPTIONS
More informationEffect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations
NDT Advance Access published November 9, 2005 Nephrol Dial Transplant (2005) 1 of 8 doi:10.1093/ndt/gfi248 Original Article Effect of previously failed kidney transplantation on peritoneal dialysis outcomes
More informationClinical Practice Guidelines : 3b - Peritoneal Dialysis. UK Renal Association Clinical Practice Guidelines 5th Edition 2007
Clinical Practice Guidelines : 3b - Peritoneal Dialysis UK Renal Association Clinical Practice Guidelines 5th Edition 2007 Prof Simon Davies Department of Nephrology University Hospital of North Staffordshire
More informationJ Am Soc Nephrol 12: , 2001
J Am Soc Nephrol 12: 2450 2457, 2001 Independent Effects of Residual Renal Function and Dialysis Adequacy on Actual Dietary Protein, Calorie, and Other Nutrient Intake in Patients on Continuous Ambulatory
More informationHow to evaluate the peritoneal membrane?
How to evaluate the peritoneal membrane? B. Bammens Brussels, May 12 2016 BELGIUM How to evaluate a hemodialyzer? How to evaluate a hemodialyzer? How to evaluate a hemodialyzer? From: Robert W. Schrier
More informationMETABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31
More informationPredictive Factors for Withdrawal from Peritoneal Dialysis: A Retrospective Cohort Study at Two Centers in Japan
Advances in Peritoneal Dialysis, Vol. 33, 2017 Yasuhiro Taki, 1 Tsutomu Sakurada, 2 Kenichiro Koitabashi, 2 Naohiko Imai, 1 Yugo Shibagaki 2 Predictive Factors for Withdrawal from Peritoneal Dialysis:
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES
Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationThe Physiology of Peritoneal Dialysis As Related To Drug Removal
The Physiology of Peritoneal Dialysis As Related To Drug Removal Thomas A. Golper, MD, FACP, FASN Vanderbilt University Medical Center Nashville, TN thomas.golper@vanderbilt.edu Clearance By Dialysis Clearance
More informationThe low ph of conventional peritoneal dialysis (PD) solutions,
Peritoneal Dialysis International, Vol. 29, pp. 158 162 Printed in Canada. All rights reserved. 0896-8608/09 $3.00 +.00 Copyright 2009 International Society for Peritoneal Dialysis EFFECTS OF IONIZED SODIUM
More informationSuperior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis
original article http://www.kidney-international.org 26 International Society of Nephrology Superior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal
More informationTHERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 2 Outline of Presentation Refinements in our understanding
More informationEffects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial
J Am Soc Nephrol 13: 1307 1320, 2002 Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial RAMÓN PANIAGUA,* DANTE AMATO,*
More informationIntermittent peritoneal dialysis (IPD) has occasionally
Peritoneal Dialysis International, Vol. 32, pp. 142 148 doi: 10.3747/pdi.2011.00027 0896-8608/12 $3.00 +.00 Copyright 2012 International Society for Peritoneal Dialysis INTERMITTENT PERITONEAL DIALYSIS:
More informationCorrelation of Residual Diuresis with MIS Score and Nutritional Status in Peritoneal Dialysis Patients: A Croatian Nationwide Study
BANTAO Journal 2015; 13(2): 59-67; doi:10.1515/bj-2015-0014 59 BJ BANTAO Journal Original article Correlation of Residual Diuresis with MIS Score and Nutritional Status in Peritoneal Dialysis Patients:
More informationGeriatric Nutritional Risk Index, home hemodialysis outcomes 131
Subject Index Aksys PHD system 113 Anemia, home outcomes 111, 172, 173 Automated peritoneal dialysis dialysis comparison 17, 18 selection factors 18, 19 telemedicine system 19 21 Blood pressure -peritoneal
More informationPeritoneal Dialysis International, Vol. 16, pp /96$300+00
Peritoneal Dialysis International, Vol. 16, pp 302-306 0896-8608/96$300+00 Printed in Canada All rights reserved Copyright 1996 International Society for Peritoneal Dialysis CONTINUOUS PERITONEAL DIAL
More informationSmart APD prescription. Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong
Smart APD prescription Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong Costing Comparison of Different Modes of RRT in Hong Kong in 2011 (Per Year) HK$300,000 HK$250,000 HK$200,000 HK$150,000
More informationObesity predicts long survival in patients on hemodialysis
Peritoneal Dialysis International, Vol. 22, pp. 506 512 Printed in Canada. All rights reserved. 0896-8608/02 $3.00 +.00 Copyright 2002 International Society for Peritoneal Dialysis NUTRITION INDICES IN
More informationPERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond
PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond John Burkart, M.D. Wake Forest University Baptist Medical Center CMO Health Systems Management 8/2014 John M. Burkart, MD Educational Grants
More informationTHE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE
THE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE THE DIALYSIS CYCLE /TIME DESIGN OF THE NATIONAL COOPERATIVE DIALYSIS STUDY
More informationMalnutrition and inflammation in peritoneal dialysis patients
Kidney International, Vol. 64, Supplement 87 (2003), pp. S87 S91 Malnutrition and inflammation in peritoneal dialysis patients PAUL A. FEIN, NEAL MITTMAN, RAJDEEP GADH, JYOTIPRAKAS CHATTOPADHYAY, DANIEL
More informationPhosphate Clearance in Peritoneal Dialysis: Automated PD Compared with Continuous Ambulatory PD
Advances in Peritoneal Dialysis, Vol. 28, 2012 Dixie-Ann Sawin, Rainer Himmele, Jose A. Diaz Buxo Phosphate Clearance in Peritoneal Dialysis: Automated PD Compared with Continuous Ambulatory PD Although
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Optimising small solute clearances in peritoneal dialysis GUIDELINES
Optimising small solute clearances in peritoneal dialysis Date written: August 2004 Final submission: December 2004 GUIDELINES a. Aim to maintain residual renal function (RRF). Consider the use of ace
More informationMETHODS RESULTS. Patients
ORIGINAL ARTICLE Korean J Intern Med 2014;29:489-497 Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients Soon Mi Hur, Hye Young Ju, Moo Yong Park, Soo Jeong Choi,
More informationNo increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months
Pagniez et al. BMC Nephrology (2017) 18:278 DOI 10.1186/s12882-017-0690-7 RESEARCH ARTICLE No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four
More informationOriginal Article ABSTRACT
Original Article Peritoneal Equilibration Test (PET) Analysis among Filipino Children on Chronic Peritoneal Dialysis at the National Kidney and Transplant Institute: A Cross-Sectional Study Elmer Kent
More informationThe Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)
The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) Thomas A. Golper MD, FACP, FASN Vanderbilt University Medical Center
More informationFailure to obtain adequate rates of ultrafiltration (UF) is
Page 1 of 6 Peritoneal Dialysis International Peritoneal Dialysis International, inpress www.pdiconnect.com 0896-8608/16 $3.00 +.00 Copyright 2016 International Society for Peritoneal Dialysis ANALYSIS
More informationOverweight Rather Than Malnutrition Is Widely Prevalent in Peritoneal Dialysis Patients
Advances in Peritoneal Dialysis, Vol. 25, 2009 Ana P. Bernardo, 1 Isabel Fonseca, 2 Anabela Rodrigues, 2 Maria J. Carvalho, 2 António Cabrita 2 Overweight Rather Than Malnutrition Is Widely Prevalent in
More informationPD In Acute Kidney Injury. February 7 th -9 th, 2013
PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of
More informationI. CLINICAL PRACTICE GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY
I. CLINICAL PRACTICE GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY GUIDELINE 1. INITIATION OF DIALYSIS 1.1 Preparation for kidney failure: Patients who reach chronic kidney disease (CKD) stage 4 (estimated
More informationClinical Grand Rounds BY AL ETINGER AUGUST 2015
Clinical Grand Rounds BY AL ETINGER AUGUST 2015 The Case 51M with a PMHx of ESRD secondary to DM on peritoneal dialysis, type 1 DM, CAD s/p CABG, HFrEF s/p ICD, HTN presents with substernal chest pain.
More informationHKMA Community Network HT Management Program
HKMA Community Network HT Management Program Peritoneal Dialysis and Hypertension Dr Siu Yui Pong, Gordon Review of Target BP in non-dialysis CKD patients What are the guidelines? DOQI (Dialysis Outcomes
More informationGambrosol Trio, clinical studies 91 Glitazone, malnutrition-inflammationatherosclerosis
Subject Index Acidosis, see Metabolic acidosis Activated carbon, sorbents 337 Adipokines adipose tissue and systemic inflammation 169 functions 167 169 prospects for study in renal patients 171 Adiponectin,
More information